TP53 and neoplasm: Wild type TP53 negatively regulates the expression of the androgen receptor (AR) in prostate cancer cell lines [19] indicating that both AR and p53 regulate each other, and that intact tumor suppressor function of p53 tends to inhibit androgen signaling whereas loss of TP53 enhances AR signaling.